X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (37) 37
male (32) 32
female (30) 30
child (27) 27
adolescent (25) 25
children (25) 25
psychiatry (24) 24
index medicus (21) 21
adult (20) 20
autism (20) 20
drug therapy (17) 17
adolescents (16) 16
adults (16) 16
risperidone (16) 16
double-blind method (14) 14
pediatrics (14) 14
antipsychotic agents - therapeutic use (13) 13
mental-retardation (13) 13
pervasive developmental disorders (13) 13
pharmacology & pharmacy (13) 13
treatment outcome (13) 13
double-blind (11) 11
middle aged (11) 11
risperidone - therapeutic use (11) 11
aggression - drug effects (10) 10
article (9) 9
autism spectrum disorder - drug therapy (9) 9
mental disorders (9) 9
psychiatric status rating scales (9) 9
care and treatment (8) 8
developmental disabilities (8) 8
mental retardation (8) 8
psychology, developmental (8) 8
rehabilitation (8) 8
antipsychotic agents - adverse effects (7) 7
genetics & heredity (7) 7
health aspects (7) 7
outcomes of treatment (7) 7
symptoms (7) 7
aggression (6) 6
autistic disorder - drug therapy (6) 6
behavior disorders (6) 6
child, preschool (6) 6
children & youth (6) 6
cross-over studies (6) 6
education, special (6) 6
aberrant behavior (5) 5
autistic children (5) 5
body weight (5) 5
clinical trials (5) 5
intellectual disability - drug therapy (5) 5
intellectual disability - psychology (5) 5
risperidone - adverse effects (5) 5
self-injurious behavior - drug therapy (5) 5
self-injurious-behavior (5) 5
surveys and questionnaires (5) 5
weight gain - drug effects (5) 5
weight-gain (5) 5
aberrant behavior checklist (4) 4
aggression - psychology (4) 4
antipsychotic drugs (4) 4
attention deficit hyperactivity disorder (4) 4
autism spectrum disorder (4) 4
autism spectrum disorders (4) 4
autistic disorder - psychology (4) 4
behavior (4) 4
behavior change (4) 4
behavior problems (4) 4
dosage and administration (4) 4
dose-response relationship, drug (4) 4
follow-up studies (4) 4
hyperactivity (4) 4
irritable mood - drug effects (4) 4
loxapine (4) 4
metaanalysis (4) 4
methylphenidate (4) 4
original articles (4) 4
parent training (4) 4
prospective studies (4) 4
psychology (4) 4
schizophrenia (4) 4
valproic acid - therapeutic use (4) 4
weight gain (4) 4
young adult (4) 4
adult education (3) 3
aged (3) 3
analysis (3) 3
antipsychotic agents - administration & dosage (3) 3
atomoxetine (3) 3
attention deficit disorder (3) 3
attention deficit disorder with hyperactivity - drug therapy (3) 3
autistic disorder (3) 3
behavioral disciplines and activities (3) 3
body mass index (3) 3
child and school psychology (3) 3
child development disorders, pervasive - drug therapy (3) 3
chromosome deletion (3) 3
comorbidity (3) 3
complications and side effects (3) 3
depression (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA Psychiatry, ISSN 2168-622X, 09/2016, Volume 73, Issue 9, pp. 928 - 937
Journal Article
Circulation, ISSN 0009-7322, 05/2010, Volume 121, Issue 17, pp. 1941 - 1950
Journal Article
Nature Reviews Neurology, ISSN 1759-4758, 11/2014, Volume 10, Issue 11, pp. 643 - 660
Journal Article
American Academy of Child and Adolescent Psychiatry. Journal, ISSN 0890-8567, 10/2016, Volume 55, Issue 10, pp. 868 - 868
Objective: The authors previously reported on a 2-by-2 randomized clinical trial of individual and combined treatment with atomoxetine (ATX) and parent... 
Journal Article
Journal of the American Academy of Child & Adolescent Psychiatry, ISSN 0890-8567, 10/2017, Volume 56, Issue 10, pp. 849 - 856.e6
Journal Article
Journal of Autism and Developmental Disorders, ISSN 0162-3257, 4/2016, Volume 46, Issue 4, pp. 1344 - 1353
Loxapine substitution is a promising option for patients with autism spectrum disorder (ASD) who develop antipsychotic-induced metabolic illness. We performed... 
Pediatrics | Loxapine | Metabolic side effects | Child and School Psychology | Neurosciences | Public Health | Atypical antipsychotics | Psychology | Autism spectrum disorder | METAANALYSIS | BEHAVIOR | PSYCHOLOGY, DEVELOPMENTAL | ADULTS | SCHIZOPHRENIA | AUTISM SPECTRUM DISORDERS | CHILDREN | ADOLESCENTS | INDUCED WEIGHT-GAIN | Autism | Body Weight | Pervasive Developmental Disorders | Drug Therapy | Adults | Physiology | Mental Health | Adolescents | Symptoms (Individual Disorders) | Loxapine - therapeutic use | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Medical Records | Autism Spectrum Disorder - complications | Male | Irritable Mood - drug effects | Metabolic Syndrome - chemically induced | Metabolic Syndrome - drug therapy | Metabolic Syndrome - complications | Young Adult | Antipsychotic Agents - antagonists & inhibitors | Antipsychotic Agents - therapeutic use | Adolescent | Adult | Female | Autism Spectrum Disorder - drug therapy | Complications and side effects | Care and treatment | Antipsychotic drugs | Pervasive developmental disorders | Influence | Research | Health aspects | Adolescence | Neuroleptics | Schizophrenia | Irritability | Systematic review | Metabolic syndrome | Weight gain | Psychotropic drugs | Blood pressure | Teenagers | Drug dosages | Offending | University colleges | Body Mass Index | Impressions | Fasting | Dopamine | Weight loss | Autistic spectrum disorders | Autistic children | Chart reviews | Weight control | Psychopharmacology | Reversal | Diabetes | Psychiatry | Induced
Journal Article
Europe’s Journal of Psychology, ISSN 1841-0413, 02/2010, Volume 6, Issue 1, p. 150
  By Karin Windt Notable in the growing literature base on attentional difficulties, distractibility and impulsivity currently described and studied as... 
Journal Article
Journal Article